Join
Live feed
·
PRReleasevia Quantisnow
Lumos Pharma Inc. logo

Lumos Pharma Reports Full Year 2021 Financial Results and Announces Plan to Perform Interim Analyses of OraGrowtH Trials

ByQuantisnow·Wall Street's wire, on your screen.
LUMO· Lumos Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track LUMO (Lumos Pharma Inc.) and more on Quantisnow.